UK approval will likely follow that, so realistic availability is 2027 at the earliest and with private prescription first
It also plays an essential role in tissue building and repair and can be beneficial for those with liver damage (Anderson, 1998)
The most common include: Genital yeast infections (more common in women) Urinary tract infections Increased urination or thirst Mild dehydration More serious risks, though less common, include: Ketoacidosis , even in the absence of high blood sugar Acute kidney injury , especially in volume-depleted patients Lower limb amputation risk , though more frequently reported with other SGLT2 inhibitors like canagliflozin To minimize these risks, patients should stay well-hydrated, maintain proper hygiene, and report unusual symptoms such as severe fatigue or nausea
Shares of Hims & Hers are up 38% this year
Metabolic outcomes Semaglutide reduced HbA 1c and body weight compared with placebo regardless of baseline metformin use (Fig